Wilmar International Limited (RTHA.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 03:29PM CEST
| Previous close | 2.1880 |
| Open | 2.2010 |
| Bid | 2.2130 x 559600 |
| Ask | 2.2770 x 543600 |
| Day's range | 2.1920 - 2.2010 |
| 52-week range | 2.1460 - 2.8540 |
| Volume | |
| Avg. volume | 1,054 |
| Market cap | 13.881B |
| Beta (5Y monthly) | 0.51 |
| PE ratio (TTM) | 9.53 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.12 (5.32%) |
| Ex-dividend date | 29 Apr 2024 |
| 1y target est | N/A |
- PR Newswire
Cerecin forges strategic partnership with A*STAR's Institute of Molecular and Cell Biology (IMCB) in Singapore to advance R&D in neurological disorders.
Cerecin Inc., a clinical-stage biotechnology company at the forefront of developing innovative neurotherapeutics, is pleased to announce the establishment of a Memorandum of Understanding (MOU) with A*STAR's Institute of Molecular and Cell Biology (IMCB). This collaboration aims to accelerate research and treatment initiatives for neurological disorders and diseases to enhance overall health and brain function.
© 2024 Yahoo. All rights reserved.